Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

International Nursing Organizations II

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...

Methods Of Healthcare Delivery System

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Sustainable Development

Sustainable Development

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tracking the Track-and-Trace: two waves of cigarette pack surveys on tax administration in Pakistan.

Tobacco control·2026

Same author

Estimating the Size of Illicit Cigarette Trade and Tax Evasion in Zambia: Results from the Empty Pack Survey Method.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2025

Same author

Differential effects of tobacco taxation across educational groups: evidence from Poland.

Tobacco control·2025

Same author

Exposure, Access, Susceptibility to, and Use of Nicotine and Tobacco Products Among 10-16-Year-Olds: National Cross-Sectional Survey of 14 232 In-School and Out-of-School Children in Pakistan.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2025

Same author

The impact of the GST reform on state-level tobacco use prevalence in India.

Tobacco control·2025

Same author

The illicit cigarette market in the Democratic Republic of the Congo (DRC): Findings from a cross-sectional study of empty cigarette packs.

PLOS global public health·2025

Search research articles

Related Experiment Video

Updated: May 31, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Development assistance for global tobacco control.

Hana Ross¹, Michal Stoklosa

¹International Tobacco Control Research, American Cancer Society, 250 Williams Street, Atlanta, GA 30303, USA. hana.ross@cancer.org

Tobacco Control

|June 18, 2011

Summary

This summary is machine-generated.

Global tobacco control funding, Development Assistance to Control Tobacco (DACT), increased significantly from 2000-2009, yet remains insufficient. Additional funding is crucial for low-resource countries to combat the tobacco epidemic.

More Related Videos

Screening of Tobacco Genotypes for Phytophthora nicotianae Resistance

Screening of Tobacco Genotypes for Phytophthora nicotianae Resistance

Published on: April 15, 2022

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Related Experiment Videos

Last Updated: May 31, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

Screening of Tobacco Genotypes for Phytophthora nicotianae Resistance

Screening of Tobacco Genotypes for Phytophthora nicotianae Resistance

Published on: April 15, 2022

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Area of Science:

Global Health
Public Health Policy
Development Economics

Background:

The global tobacco epidemic is projected to cause over 8 million deaths annually by 2030, disproportionately affecting low-resource nations.
Despite the severe impact, global funding for tobacco control remains poorly understood.

Purpose of the Study:

To estimate the financial resources allocated to global tobacco control, with a specific focus on low- and middle-income countries.
To analyze trends in Development Assistance to Control Tobacco (DACT) from 2000 to 2009.

Main Methods:

An integrated database was compiled using information from tobacco control donors.
Analysis focused on DACT provided to low- and middle-income countries.

Main Results:

Global DACT surged from US$1.2 million in 2000 to US$44.2 million in 2009, largely driven by private philanthropy.
Per adult funding remained low, with significant disparities, as 28% of countries received no DACT and 15% reported no funding at all.
DACT constituted a minimal fraction (0.09%) of overall health-related development assistance in 2007.

Conclusions:

Existing funding for infectious and non-communicable diseases in low-resource settings is inadequate.
Generating additional, dedicated funding for tobacco control is essential, rather than reallocating resources from other public health priorities.
Mechanisms for increasing tobacco control funding are proposed.